A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas

Steven Attia, Jill Kolesar, Michelle R. Mahoney, Henry C. Pitot, Daniel Laheru, James Heun, Wei Huang, Jens Eickhoff, Charles Erlichman, Kyle D. Holen

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Fingerprint Dive into the research topics of 'A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas'. Together they form a unique fingerprint.

Medicine & Life Sciences